References
- Porkka K, Biomgvist C, Rissanen P, Elomaa I, Pyrnanen S. Salvage therapies in women who fail to respond to first line treatment with fluorouracil, epirubicin, and cyclophos-phamide for advanced breast cancer. J Clin Oncol 1994; 12 (8): 1639–47.
- Henderson IC, Allegra JC, Woodcock TH et al. Randomized clinical trial comparing mitoxontrone with dox-orubicin in previously treated patients with metastatic breast cancer. J Clin Oncol 1989; 7: 560–571.
- Van-Hoef ME, Baumann I, Longe C et al. Dose escalat-ing induction chemotherapy supported by lenogastrim pre-ceding high dose consolidation chemotherapy for advanced breast cancer. Selection of the most acceptable regimen to induce maximal tumor response and investigation of the opti-mal time to collect peripheral blood progenitor cells for haematological rescue after high dose consolidation chemotherapy. Ann Oncol 1994; 5 (3): 217–224.
- Comis RC. Oral etoposide in oncology: an evolving role. Ann Oncol 1992; 3: 63–67.
- Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981; 47: 207–214.
- Cavalli F, Jungi WF, Brunner KW. Randomisierte Phase II Studie mit V1316_213 (Etoposide) in der Behandlung vom Fortgeschrittenen Mammakarzinom. Onkologie 1981; 4: 80–83.
- Falkson G, van Deyk JJ, van Eden EB, van der Merwe AM, van den Bergh JA, Falkson HC. A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-3-diethylidene glucoside (NSC 141540), VP16-213. Cancer 1975; 35: 1141-1144.
- Calvert AH, Lind MJ, Millward MM, et al. Long-term oral etoposide in metastatic breast cancer: clinical and phar-macokinetic results. Cancer Treat Rev 1993; 19, suppl. C: 27-33.
- Cerar D, Cervek J, Cufer T. Salvage chemotherapy with oral etoposide in metastatic breast cancer—preliminary report. Ann Oncol 1992; 3 (Suppl 5, abst): 84.
- Valagussa P, Bambrilla C, Bonadonna G. Chemotherapy of advanced disease. In: Hoogstraten B, Burn I, Bloom HJG ( eds), Breast Cancer, Berlin, Germany, Springer-Verlag, 1989: 235-256.
- Martin MM, Luch A, Casado A, et al. Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer. J Chin Oncol 1994; 12 (5): 986–991.
- Bontebal M, Planting AST, Verweij J et al. Second-line chemotherapy with long-trem low-dose oral etoposide in patients with advanced breast cancer. Breast Cancer Res Treat 1995; 34: 185–189.
- Palombo H, Estabe J, Vinolas N et al. Chronic oral etoposide in advanced breast cancer. Cancer Chemother Pharmacol 1994; 33 (6): 52–59.